Found: 5000
Select item for more details and to access through your institution.
The innate defenders: a review of natural killer cell immunotherapies in cancer.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2024.1482807
- By:
- Publication type:
- Article
ASHP and ASHP Foundation Pharmacy Forecast 2025: Strategic Planning Guidance for Pharmacy Departments in Hospitals and Health Systems.
- Published in:
- American Journal of Health-System Pharmacy, 2025, v. 82, n. 2, p. 17, doi. 10.1093/ajhp/zxae280
- By:
- Publication type:
- Article
Harnessing cytokine-induced killer cells to accelerate diabetic wound healing: an approach to regulating post-traumatic inflammation.
- Published in:
- Regenerative Biomaterials, 2024, v. 11, p. 1, doi. 10.1093/rb/rbad116
- By:
- Publication type:
- Article
Optimization and Standardization of Stable De-Epidermized Dermis (DED) Models for Functional Evaluation of Cutaneous Cell Therapies.
- Published in:
- Bioengineering (Basel), 2024, v. 11, n. 12, p. 1297, doi. 10.3390/bioengineering11121297
- By:
- Publication type:
- Article
Intervertebral Disc Degeneration and Regeneration: New Molecular Mechanisms and Therapeutics: Obstacles and Potential Breakthrough Technologies.
- Published in:
- Cells (2073-4409), 2024, v. 13, n. 24, p. 2103, doi. 10.3390/cells13242103
- By:
- Publication type:
- Article
Methuosis, Alkaliptosis, and Oxeiptosis and Their Significance in Anticancer Therapy.
- Published in:
- Cells (2073-4409), 2024, v. 13, n. 24, p. 2095, doi. 10.3390/cells13242095
- By:
- Publication type:
- Article
Cell Therapy as a Way to Increase the Effectiveness of Hematopoietic Stem Cell Transplantation.
- Published in:
- Cells (2073-4409), 2024, v. 13, n. 24, p. 2056, doi. 10.3390/cells13242056
- By:
- Publication type:
- Article
From Bench to Bedside: Translating Cellular Rejuvenation Therapies into Clinical Applications.
- Published in:
- Cells (2073-4409), 2024, v. 13, n. 24, p. 2052, doi. 10.3390/cells13242052
- By:
- Publication type:
- Article
Contents Vol. 33, 2020.
- Published in:
- 2020
- Publication type:
- Table of Contents
Autologous Cell Therapy for Aged Human Skin: A Randomized, Placebo-Controlled, Phase-I Study.
- Published in:
- Skin Pharmacology & Physiology, 2020, v. 33, n. 1, p. 9, doi. 10.1159/000502240
- By:
- Publication type:
- Article
Skin Substitutes and Wound Healing.
- Published in:
- Skin Pharmacology & Physiology, 2009, v. 22, n. 2, p. 94, doi. 10.1159/000178868
- By:
- Publication type:
- Article
Whole-Cell Bioprocessing of Human Fetal Cells for Tissue Engineering of Skin.
- Published in:
- Skin Pharmacology & Physiology, 2009, v. 22, n. 2, p. 63, doi. 10.1159/000178865
- By:
- Publication type:
- Article
Investigation of Growth Conditions for the Expansion of Porcine Mesenchymal Stem Cells on Microcarriers in Stirred Cultures.
- Published in:
- Applied Biochemistry & Biotechnology, 2014, v. 172, n. 2, p. 1004, doi. 10.1007/s12010-013-0586-3
- By:
- Publication type:
- Article
Temperature and pH-Tunable Fluorescence Nanoplatform with Graphene Oxide and BODIPY-Conjugated Polymer for Cell Imaging and Therapy.
- Published in:
- Macromolecular Rapid Communications, 2013, v. 34, n. 17, p. 1408, doi. 10.1002/marc.201300413
- By:
- Publication type:
- Article
Frontispiece: Cell‐Surface Engineering for Advanced Cell Therapy.
- Published in:
- Chemistry - A European Journal, 2018, v. 24, n. 59, p. N.PAG, doi. 10.1002/chem.201885963
- By:
- Publication type:
- Article
Cell‐Surface Engineering for Advanced Cell Therapy.
- Published in:
- Chemistry - A European Journal, 2018, v. 24, n. 59, p. 15725, doi. 10.1002/chem.201801710
- By:
- Publication type:
- Article
An Extracellular miRNA‐Responsive Artificial Receptor via Dynamic DNA Nano‐assembly for Biomarker‐Driven Therapy.
- Published in:
- Angewandte Chemie, 2023, v. 135, n. 31, p. 1, doi. 10.1002/ange.202305227
- By:
- Publication type:
- Article
Phosphorothioated DNA Engineered Liposomes as a General Platform for Stimuli‐Responsive Cell‐Specific Intracellular Delivery and Genome Editing.
- Published in:
- Angewandte Chemie, 2023, v. 135, n. 25, p. 1, doi. 10.1002/ange.202303973
- By:
- Publication type:
- Article
Cu Single Atom Nanozyme Based High‐Efficiency Mild Photothermal Therapy through Cellular Metabolic Regulation.
- Published in:
- Angewandte Chemie, 2022, v. 134, n. 50, p. 1, doi. 10.1002/ange.202209245
- By:
- Publication type:
- Article
Manipulation of Multiple Cell–Cell Interactions by Tunable DNA Scaffold Networks.
- Published in:
- Angewandte Chemie, 2022, v. 134, n. 7, p. 1, doi. 10.1002/ange.202111151
- By:
- Publication type:
- Article
Mesenchymal stromal cells for acute graft‐versus‐host disease: response at 1 week predicts probability of survival.
- Published in:
- Angewandte Chemie, 2019, v. 131, n. 15, p. 89, doi. 10.1111/bjh.15749
- By:
- Publication type:
- Article
Structural parameters of nanoparticles affecting their toxicity for biomedical applications: a review.
- Published in:
- Journal of Nanoparticle Research, 2023, v. 25, n. 3, p. 1, doi. 10.1007/s11051-023-05690-w
- By:
- Publication type:
- Article
Acid-responsive drug-loaded copper phosphate nanoparticles for tumor cell therapy through synergistic apoptosis and ferroptosis strategy.
- Published in:
- Journal of Nanoparticle Research, 2023, v. 25, n. 1, p. 1, doi. 10.1007/s11051-022-05655-5
- By:
- Publication type:
- Article
Cell biophysical characteristics of PPy-GNPs and their application in photothermal therapy of SKOV-3 cell.
- Published in:
- Journal of Nanoparticle Research, 2020, v. 22, n. 9, p. N.PAG, doi. 10.1007/s11051-020-04993-6
- By:
- Publication type:
- Article
Aptamer-based selective KB cell killing by the photothermal effect of gold nanorods.
- Published in:
- Journal of Nanoparticle Research, 2019, v. 21, n. 6, p. N.PAG, doi. 10.1007/s11051-019-4561-y
- By:
- Publication type:
- Article
Iltamiocel Autologous Cell Therapy for the Treatment of Female Stress Urinary Incontinence: A Double‐Blind, Randomized, Stratified, Placebo‐Controlled Trial.
- Published in:
- Neurourology & Urodynamics, 2024, v. 43, n. 8, p. 2290, doi. 10.1002/nau.25588
- By:
- Publication type:
- Article
Allogeneic transplantation for adult T‐cell leukemia/lymphoma in adolescent and young adults and young patients: A nationwide retrospective study by the ATL working group of the Japan society for transplantation and cellular therapy.
- Published in:
- Hematological Oncology, 2024, v. 42, n. 6, p. 1, doi. 10.1002/hon.3315
- By:
- Publication type:
- Article
Cellular therapy in lymphoma.
- Published in:
- Hematological Oncology, 2024, v. 42, n. 6, p. 1, doi. 10.1002/hon.3200
- By:
- Publication type:
- Article
Central nervous system lymphomas—Assessment and treatment and prevention of central nervous system relapse.
- Published in:
- Hematological Oncology, 2024, v. 42, n. 6, p. 1, doi. 10.1002/hon.3197
- By:
- Publication type:
- Article
Hematopoietic cell transplantation and cellular therapies in Switzerland. Evolution over 25 years. A report from the stem cell transplantation and cellular therapies working groups of the SBST 1997–2021.
- Published in:
- Hematological Oncology, 2024, v. 42, n. 1, p. 1, doi. 10.1002/hon.3241
- By:
- Publication type:
- Article
Single‐unit unrelated cord blood transplantation versus HLA‐matched sibling transplantation in adults with advanced myelodysplastic syndrome: A registry‐based study from the adult MDS working group of the Japanese society for transplantation and cellular therapy
- Published in:
- Hematological Oncology, 2024, v. 42, n. 1, p. 1, doi. 10.1002/hon.3217
- By:
- Publication type:
- Article
Risk factors for fatal cardiac complications after allogeneic hematopoietic cell transplantation: Japanese Society for Transplantation and Cellular Therapy transplant complications working group.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 3, p. 535, doi. 10.1002/hon.3101
- By:
- Publication type:
- Article
NX‐0255 AND NX‐1607, SMALL MOLECULE INHIBITORS OF CBL‐B, ARE EFFICACIOUS IN COMBINATION WITH ADOPTIVE CELL THERAPY OR RITUXIMAB IN PRECLINICAL MOUSE MODELS OF LYMPHOMA.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 796, doi. 10.1002/hon.3165_643
- By:
- Publication type:
- Article
UPFRONT RADIATION THERAPY FOR POST‐STEM CELL TRANSPLANT MULTIPLE MYELOMA PATIENTS WITH OLIGO‐RELAPSE/PROGRESSIVE DISEASE: FACTORS ASSOCIATED WITH FAVORABLE OUTCOMES.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 780, doi. 10.1002/hon.3165_629
- By:
- Publication type:
- Article
FIRST IN HUMAN STUDY OF AUTO4, A TRBC1‐TRAGETTING CART T CELL THERAPY IN RELAPSED/REFRACTORY TRBC1‐POSITIVE PERIPHERAL T‐CELL LYMPHOMA.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 80, doi. 10.1002/hon.3163_44
- By:
- Publication type:
- Article
Neurotoxicity in patients with CNS lymphomas treated with CAR‐T cell therapy. A LOC network study.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 536, doi. 10.1002/hon.3164_398
- By:
- Publication type:
- Article
Multicenter experience with radiotherapy for relapse after chimeric antigen receptor T cell therapy in non‐Hodgkin lymphoma.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 532, doi. 10.1002/hon.3164_395
- By:
- Publication type:
- Article
Responses after Allogeneic NK Cell Therapy for Lymphoma: correlative analysis revealed impact of host monocytes and robust T cells tumor trafficking.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 518, doi. 10.1002/hon.3164_383
- By:
- Publication type:
- Article
Prognostic factors for cellular therapies ‐ CART and allogeneic SCT ‐ in relapsed /refractory large B cell lymphoma (LBCL).
- Published in:
- Hematological Oncology, 2023, v. 41, p. 449, doi. 10.1002/hon.3164_331
- By:
- Publication type:
- Article
Trends in relative survival of Diffuse large B‐cell lymphoma in Sweden in the era of targeted and cellular therapies.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 429, doi. 10.1002/hon.3164_316
- By:
- Publication type:
- Article
BONE MARROW VOLUME IRRADIATED AND RISK OF CYTOPENIAS IN AGGRESSIVE B‐CELL LYMPHOMA PATIENTS BRIDGED WITH RADIATION THERAPY FOR CART CELL THERAPY.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 222, doi. 10.1002/hon.3163_145
- By:
- Publication type:
- Article
CELL‐FREE DNA KINETICS DECIPHER POTENTIAL MECHANISMS OF ACTION OF IBRUTINIB COMBINATION THERAPY IN MANTLE CELL LYMPHOMA (MCL).
- Published in:
- Hematological Oncology, 2023, v. 41, p. 181, doi. 10.1002/hon.3163_114
- By:
- Publication type:
- Article
A unique hub-and-spoke model to optimize patient management in lymphoma using novel CAR-T cell therapy in Southeast and South Asia.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Efficacy and follow‐up of humanized anti‐BCMA CAR‐T cell therapy in relapsed/refractory multiple myeloma patients with extramedullary‐extraosseous, extramedullary‐bone related, and without extramedullary disease.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 2, p. 223, doi. 10.1002/hon.2958
- By:
- Publication type:
- Article
Humanized anti‐CD19 chimeric antigen receptor‐T cell therapy is safe and effective in lymphoma and leukemia patients with chronic and resolved hepatitis B virus infection.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 1, p. 75, doi. 10.1002/hon.2807
- By:
- Publication type:
- Article
Recent advances in chimeric antigen receptor natural killer cell therapy for overcoming intractable hematological malignancies.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 1, p. 11, doi. 10.1002/hon.2802
- By:
- Publication type:
- Article
Evidence of long-lasting anti-CD19 activity of engrafted CD19 chimeric antigen receptor-modified T cells in a phase I study targeting pediatrics with acute lymphoblastic leukemia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The acceleration of CAR-T therapy in non-Hodgkin lymphoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
CD19‐DIRECTED CAR T CELL THERAPY (CTL019) FOR RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL AND FOLLICULAR LYMPHOMAS: FOUR YEAR OUTCOMES.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 137, doi. 10.1002/hon.96_2629
- By:
- Publication type:
- Article
MDS AS A CAUSE FOR PROLONGED HEMATOLOGIC TOXICITY AFTER TREATMENT WITH CD19 TARGETED CAR‐T CELL THERAPY IN PATIENTS WITH RELAPSED REFRACTORY LYMPHOMA.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 507, doi. 10.1002/hon.190_2631
- By:
- Publication type:
- Article